Testimonials

Small Molecules

Biological Therapeutics

New Targets

Diagnostics

Enabling Technology

Antibody Catalogue

Register

Privileged Access Section

Anti-Blood group A sugar determinant Antibody Profile

Antigen: Blood group A sugar determinant.
Relevance: 9A is suitable for binding to the EGF receptor in A431 cells only. These cells have a glycosylation defect which reveals otherwise cryptic sugar structures.
Clone: 9A
Subclass: IgG3
Applications: Immunoprecipitation, ELISA
Immunogen: A431 cells (human vulval squamous carcinoma cell line).
Reactivity: Human
Species raised in: Mouse
Fusion partner: P3X63/Ag8
Recommended growth conditions: DMEM + 5% FCS
References: Gullick WJ & Lemoine NR. 1990. J. Pathol. 162:275-276. PubMed Logo
Parker et al. 1984. J. Biol. Chem. 259:9906-9912. PubMed Logo
Notes: Not to be used as a EGF receptor specific reagent.

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only.  However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.

[back]